Specialty and generic pharma - Teva, Mylan, Sun Pharma + branded specialty names. Patent-cliff exposure dominates valuation; the best operators replace expiring revenue with M&A or pipeline launches faster than the cliff erodes them.
Industry leader
Sun Pharmaceutical Industries Limited SUNPHARMA.NS
Buffett-Fit: 69/100
Pharma quality is measured by pipeline depth + patent-cliff distance + capital allocation history. Mega-cap pharma (Pfizer, Merck, Johnson & Johnson, Eli Lilly, AbbVie) trade more like dividend compounders than growth stocks - slow but predictable, with periodic blockbuster windfalls.
Sorted by composite quality score - ROIC, margin stability, balance-sheet strength, growth quality. Click any ticker for the full Buffett verdict.
4.33T mcap
12.99T mcap
985.4B mcap
293.2B mcap
2.55T mcap
32.6B mcap
287.9B mcap
29.8B mcap
214.0B mcap
5.3B mcap
1.13T mcap
15.9B mcap
11.4B mcap
1.10T mcap
3.5B mcap
75.5B mcap
384.7B mcap
181.8B mcap
542.4B mcap
286.5B mcap
6.17T mcap
1.8B mcap
6.5B mcap
104.5B mcap
1.3B mcap
4.91T mcap
4.2B mcap
166.9B mcap
101.4B mcap
116.8B mcap
40.1B mcap
2.0B mcap
56.9B mcap
4.09T mcap
1.31T mcap
149.2B mcap
588M mcap
8.09T mcap
831M mcap
41.1B mcap
28.9B mcap
914M mcap
1.1B mcap
50.4B mcap
1.0B mcap
1.2B mcap
35.9B mcap
1.8B mcap
504M mcap
1.12T mcap
See all industries + sector-level statistics + framework filters.
Educational framework analysis only. Not investment advice, not a recommendation, not personalized to your situation. Always do your own research.